L&K Spine, Inc., based in Texas, a leading innovator in spinal implant technologies, today announced the successful completion of the first surgical case utilizing the BluEX-C Expandable Cervical Interbody System. The procedure was performed by Dr. Fidai in a single-level Anterior Cervical Discectomy and Fusion (ACDF) at the C5-C6 level.
The successful implantation marks an important milestone following the recent FDA 510(k) clearance of BluEX-C and represents the beginning of the system’s clinical adoption in the highly competitive anterior cervical market.
BluEX-C is an expandable cervical interbody device designed to provide surgeons with controlled, precision expansion for anterior cervical height restoration while supporting efficient surgical workflows. Developed from proven expandable technology, the system incorporates a low-profile design, proprietary surface technology, and precision instrumentation intended to facilitate reproducible surgical outcomes.
“We are excited to announce the first successful clinical use of BluEX-C and would like to thank Dr. Fidai for his confidence in our technology,” said Alex Kang, Chief Executive Officer of L&K Spine. “This milestone represents a significant achievement for our organization and reflects our commitment to delivering innovative technologies that address the evolving needs of spine surgeons and their patients.”
The procedure involved a single-level ACDF at C5-C6 utilizing BluEX-C’s expandable technology to support intervertebral height restoration and cervical alignment. The case marks the first commercial use of BluEX-C following regulatory clearance and serves as an important step in L&K Spine’s continued expansion of its cervical spine portfolio.
“One of the challenges in cervical fusion procedures is achieving precise disc height restoration while maintaining confidence in implant placement. BluEX-C provided a controlled expansion mechanism that allowed me to make adjustments in situ and achieve the desired construct efficiently. The ability to expand the implant after insertion offers a level of versatility that can be beneficial in addressing patient-specific anatomy.” – Dr. M. Fidai of California Spine
Clinical Benefits of the BluEX-C Expandable Cervical Interbody System include:
• Controlled Parallel Height Expansion
• BluEX Roughened Surface Technology
• Market-Leading Height Profile
• Precision Instrumentation
The addition of BluEX-C further strengthens L&K Spine’s growing portfolio of cervical technologies designed to support reproducible outcomes, surgeon preference, and patient-focused care.
About L&K Spine
L&K Spine, Inc., headquartered in Carrollton, TX is a U.S.-based spinal implant company dedicated to advancing spine surgery through innovative technologies and clinically focused solutions. As the U.S. subsidiary of L&K Biomed, L&K Spine markets and distributes a comprehensive portfolio of spinal implant systems designed to address the evolving needs of spine surgeons worldwide.
Contact:
Website: www.lnkspineinc.com
Email: cs@lnkspineinc.com
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
